ascopubs.org

A phase I study to determine the comparative bioavailability of two different oral formulations of the PARP inhibitor, olaparib (AZD2281), in patients with advanced solid tumors.

Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). Methods: In this randomized, ...
ascopubs.org

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.

Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicity. Twenty-nine patients received oral EP (capsules, 50 to 150 mg/m2/d of E ...
manilatimes

Life Extension Launches New Bio-Luteolin™ Supplement for Healthy Aging Benefits

Life Extension’s New Life Extension Bio-Luteolin™ formula is up to 14x more bioavailable than regular luteolin supplements. Bio-Luteolin formula supports cellular function and healthy aging. Fort ...